ICARES Medicus Statistics
Total Valuation
ICARES Medicus has a market cap or net worth of TWD 5.04 billion. The enterprise value is 5.25 billion.
Market Cap | 5.04B |
Enterprise Value | 5.25B |
Important Dates
The next estimated earnings date is Tuesday, August 12, 2025.
Earnings Date | Aug 12, 2025 |
Ex-Dividend Date | Jul 8, 2024 |
Share Statistics
ICARES Medicus has 42.57 million shares outstanding. The number of shares has increased by 7.61% in one year.
Current Share Class | 42.57M |
Shares Outstanding | 42.57M |
Shares Change (YoY) | +7.61% |
Shares Change (QoQ) | -0.32% |
Owned by Insiders (%) | 18.05% |
Owned by Institutions (%) | 0.23% |
Float | 21.01M |
Valuation Ratios
The trailing PE ratio is 39.95.
PE Ratio | 39.95 |
Forward PE | n/a |
PS Ratio | 5.06 |
PB Ratio | 2.78 |
P/TBV Ratio | 6.21 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.31, with an EV/FCF ratio of -21.19.
EV / Earnings | 41.24 |
EV / Sales | 5.27 |
EV / EBITDA | 20.31 |
EV / EBIT | 33.70 |
EV / FCF | -21.19 |
Financial Position
The company has a current ratio of 2.22, with a Debt / Equity ratio of 0.46.
Current Ratio | 2.22 |
Quick Ratio | 1.54 |
Debt / Equity | 0.46 |
Debt / EBITDA | 3.37 |
Debt / FCF | -3.40 |
Interest Coverage | 6.48 |
Financial Efficiency
Return on equity (ROE) is 4.44% and return on invested capital (ROIC) is 4.10%.
Return on Equity (ROE) | 4.44% |
Return on Assets (ROA) | 3.62% |
Return on Invested Capital (ROIC) | 4.10% |
Return on Capital Employed (ROCE) | 6.08% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.39 |
Inventory Turnover | 1.35 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +4.85% in the last 52 weeks. The beta is 0.44, so ICARES Medicus's price volatility has been lower than the market average.
Beta (5Y) | 0.44 |
52-Week Price Change | +4.85% |
50-Day Moving Average | 115.85 |
200-Day Moving Average | 129.58 |
Relative Strength Index (RSI) | 61.65 |
Average Volume (20 Days) | 25,532 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ICARES Medicus had revenue of TWD 996.44 million and earned 127.40 million in profits. Earnings per share was 2.97.
Revenue | 996.44M |
Gross Profit | 640.66M |
Operating Income | 147.67M |
Pretax Income | 177.47M |
Net Income | 127.40M |
EBITDA | 225.90M |
EBIT | 147.67M |
Earnings Per Share (EPS) | 2.97 |
Balance Sheet
The company has 726.95 million in cash and 843.30 million in debt, giving a net cash position of -116.35 million or -2.73 per share.
Cash & Cash Equivalents | 726.95M |
Total Debt | 843.30M |
Net Cash | -116.35M |
Net Cash Per Share | -2.73 |
Equity (Book Value) | 1.81B |
Book Value Per Share | 40.35 |
Working Capital | 814.09M |
Cash Flow
In the last 12 months, operating cash flow was -110.19 million and capital expenditures -137.70 million, giving a free cash flow of -247.90 million.
Operating Cash Flow | -110.19M |
Capital Expenditures | -137.70M |
Free Cash Flow | -247.90M |
FCF Per Share | -5.82 |
Margins
Gross margin is 64.29%, with operating and profit margins of 14.82% and 12.79%.
Gross Margin | 64.29% |
Operating Margin | 14.82% |
Pretax Margin | 17.81% |
Profit Margin | 12.79% |
EBITDA Margin | 22.67% |
EBIT Margin | 14.82% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.30, which amounts to a dividend yield of 0.26%.
Dividend Per Share | 0.30 |
Dividend Yield | 0.26% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 6.15% |
Buyback Yield | -7.61% |
Shareholder Yield | -7.35% |
Earnings Yield | 2.53% |
FCF Yield | -4.91% |
Stock Splits
The last stock split was on July 8, 2024. It was a forward split with a ratio of 1.1.
Last Split Date | Jul 8, 2024 |
Split Type | Forward |
Split Ratio | 1.1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |